Cytodyn Inc (CYDY)

[Blane]

1. They already have Vyera accounted for, so I’m not sure how much more you think it will cost to sell 1 product with multiple indications.

2. The drugs those other companies are selling, how many indications, how many side effects? Cytodyn, like Humira, can breeze past safety in trials given the data. Every trial they potentially want an indication with will be phase 2 or phase 2/3 which is more likely.

With revenue potential with Covid, and HIV, they could very easily push other indications forward. Not saying there couldn’t be a little dilution in the future, but I disagree that it would be likely be like other companies given the type of drug we are talking about.

Just my opinion.